Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause Article

publication date

  • 2018

webpage

keywords

  • Dehydroepiandrosterone
  • Dryness
  • Dyspareunia
  • Genitourinary syndrome of menopause
  • Intracrinology Prasterone
  • Vulvovaginal atrophy

start page

  • 1339

end page

  • 1353

volume

  • 25

issue

  • 11